These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8976172)

  • 1. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes.
    Harrison LC; Dempsey-Collier M; Kramer DR; Takahashi K
    J Exp Med; 1996 Dec; 184(6):2167-74. PubMed ID: 8976172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
    Ploix C; Bergerot I; Durand A; Czerkinsky C; Holmgren J; Thivolet C
    Diabetes; 1999 Nov; 48(11):2150-6. PubMed ID: 10535448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model.
    Hänninen A; Harrison LC
    Immunol Rev; 2000 Feb; 173():109-19. PubMed ID: 10719672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice.
    Weaver DJ; Liu B; Tisch R
    J Immunol; 2001 Jul; 167(1):586-92. PubMed ID: 11418698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
    J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.
    Aspord C; Thivolet C
    Clin Exp Immunol; 2002 Nov; 130(2):204-11. PubMed ID: 12390307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR gamma delta intraepithelial lymphocytes are required for self-tolerance.
    Locke NR; Stankovic S; Funda DP; Harrison LC
    J Immunol; 2006 Jun; 176(11):6553-9. PubMed ID: 16709812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Galactosylceramide ameliorates autoimmune diabetes in non-obese diabetic mice through a suppressive effect mediated by CD8+ T cells.
    Chuang YP; Lin YC; Sytwu HK
    Immunol Lett; 2011 Jul; 138(1):54-62. PubMed ID: 21392534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
    Tisch R; Wang B; Serreze DV
    J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium meta-arsenite prevents the development of autoimmune diabetes in NOD mice.
    Lee YS; Kim D; Lee EK; Kim S; Choi CS; Jun HS
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):254-61. PubMed ID: 25576766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral and intravenous insulin and glutamic acid decarboxylase in NOD mice.
    Ramiya VK; Shang XZ; Wasserfall CH; Maclaren NK
    Autoimmunity; 1997; 26(3):139-51. PubMed ID: 9550282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow's milk-based IDDM prevention trial.
    Karges W; Hammond-McKibben D; Cheung RK; Visconti M; Shibuya N; Kemp D; Dosch HM
    Diabetes; 1997 Apr; 46(4):557-64. PubMed ID: 9075794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
    Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
    J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
    Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
    Front Immunol; 2018; 9():290. PubMed ID: 29503651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide.
    Alleva DG; Gaur A; Jin L; Wegmann D; Gottlieb PA; Pahuja A; Johnson EB; Motheral T; Putnam A; Crowe PD; Ling N; Boehme SA; Conlon PJ
    Diabetes; 2002 Jul; 51(7):2126-34. PubMed ID: 12086942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
    Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
    Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.